Commentary on the Paper of Walther L. et al.: Phosphatidylethanol Is Superior to CDT and GGT as an Alcohol Marker and Is a Reliable Estimate of Alcohol Consumption Level. by Weinmann, Wolfgang et al.
1 
 
Commentary on the Paper of Walther L. et al. 
Phosphatidylethanol (PEth) is superior to CDT and GGT as an alcohol marker and is a reliable 
estimate of alcohol consumption level 
 
Wolfgang Weinmann1, Alexandra Schröck1, Friedrich Martin Wurst2,3 
 
1 Institute of Forensic Medicine, University of Bern, Bühlstr. 20, 3012 Bern, Switzerland 
2 Paracelsus Medical University, Strubergasse 21, A-5020 Salzburg, Austria 
3 Center for Interdisciplinary Addiction Research, University of Hamburg, Germany 
 
 
Wolfgang.weinmann@irm.unibe.ch 
 
Alexandra.Schroeck@irm.unibe.ch 
 
Corresponding author: 
Friedrich M. Wurst 
Paracelsus Medical University, 
Strubergasse 21 
5020 Salzburg 
Email: frieder.wurst@gmx.de 
 
 
The paper of Walther et al. contributes to a timely and both from a scientific as well as clinical point of 
view relevant issue, namely the role of the ethanol metabolite phosphatidylethanol (PEth) in concert 
with questionnaires and biomarkers for the assessment of ethanol intake. 
For a better understanding of strengths, potential limitations and future research needs, at first some 
aspects of the Alcohol Use Disorders Identification Test (AUDIT) and PEth are briefly recapitulated. 
 
 
Alcohol Use Disorders Identification Test (AUDIT) 
The 10-item AUDIT is a screening questionnaire developed by the World Health Organization (WHO) 
to identify harmful or hazardous alcohol consumption (Saunders et al., 1993). 
 
The AUDIT-C, consisting of the first three questions of the AUDIT (quantity, frequency and binge 
drinking) was developed as an even briefer, easy to administer screening measure. 
 
Both AUDIT and AUDIT-C are recommended by various guidelines such as of the National Institute for 
Health and Care Excellence, (NICE, UK; Jackson et al. 2010; NICE 2011), the Australian (Haber et al. 
2009) and the German evidence- and consensus based guideline of the grade S3 (Mann, Batra 2015). 
 
Neither the AUDIT nor the AUDIT-C are designed to provide a diagnosis of alcohol use disorder 
according to the International Classification of Diseases (ICD-10) or Diagnostic and Statistical Manual 
(DSM IV) criteria. Nevertheless, the probability of alcohol misuse or dependence is positively 
correlated to the AUDIT/AUDIT-C scores. Also, the first two questions allow an estimation of alcohol 
intake. 
Of note, the AUDIT is a) retrospective and b) asks about typical consumption during the last year. This 
is of importance when correlating results of the AUDIT with data obtained from an alcohol diary and 
biomarkers, which might reflect different time spectra. 
 
Phosphatidylethanol (PEth) 
PEth is a phospholipid formed in the presence of alcohol via the action of the enzyme phospholipase 
D (PLD) (Alling et al., 1983). The precursors are naturally prevalent phosphatidylcholine homologues. 
The combined sum of the PEth homologues 16:0/18:1 and 16:0/18:2, which are the most prevalent 
ones in human blood (Gnann et al., 2014) correlates better with total PEth than each of them alone 
(Zheng et al., 2011). 
PEth is formed after ingestion of alcohol and has a half-life time of approximately 4 – 10 days (Varga, 
Hansson et al. 2000, Gnann, Weinmann et al. 2012). 
During the last years, PEth has been employed in numerous settings such as assessment of driving 
ability, in forensic psychiatry, monitoring programs, and identification of alcohol intake in specific risk 
groups, e.g. for neonatal screening of prenatal alcohol exposure (for review, see Wurst et al. 2015). 
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Recently, PEth has been recommended by the German Guideline on Alcohol Use disorders for 
screening of chronic alcohol intake with the highest level of evidence (level 1) in all settings for 
assessing drinking habits. 
 
 
On this background, the paper discusses the use of alcohol biomarkers for the assessment of alcohol 
consumption levels in comparison to retrospective as well as diary-based alcohol self-reports. 
For this study, AUDIT-C, drinking diary based self-reports (6 weeks), and alcohol state marker 
concentrations (PEth, CDT, GGT, AST and ALT) have been used to investigate correlations of alcohol 
biomarkers with the level of alcohol consumption. 
 
The different biomarkers, questionnaires and self-reports represent different time frames. While the 
AUDIT and AUDIT-C ask for typical alcohol consumption during the last year, self-reports using a 
diary, reflect the daily alcohol intake of the last weeks. The alcohol biomarkers such as PEth, CDT and 
GGT have a detection window in the range of several weeks depending on the amount of consumed 
alcohol. 
PEth – with a half-life time of 4 to 10 days - represents a period which is closer to the time of blood 
sampling. In cases of high daily doses, this will not make much of a difference, due to accumulation of 
PEth in blood. For assessing the sensitivity of the marker PEth, the patients have been grouped in 
three categories, those with intake of 0 – 49 g ethanol/day, 50 – 99 g ethanol/day and ≥ 100 g 
ethanol/day. Biomarkers have been determined at the start of study and in week 6. Self-reported 
doses of ethanol at baseline (prior the start of the study) and in week 6 have been compared with 
AUDIT score, AUDIT-C score and the alcohol biomarkers. The reason for this classification however 
remains unclear and is obviously not based on frequently used classifications or recommendations, 
which would be of importance with regard to clinical meaningfulness and for potential comparisons. 
 
Concerning PEth 16:0/18:1, the decision limits (“cut-offs”) have been tested for their sensitivity for the 
reported alcohol consumption levels (0 – 49 g/day, 50 – 99 g/day and ≥ 100 g/day). According to an 
agreement between Swedish laboratories the limits of decision for excessive alcohol consumption has 
been defined at > 0.3 μmol/L and for low or no alcohol consumption at < 0.05 μmol/L (Helander and 
Hansson, 2013). In addition, the limit of quantification (LOQ: 0.02 μmol/L) of the used LC-MS/MS 
method for PEth detection was also tested as “cut-off” in this paper. For the group with low doses (0 – 
49 g ethanol per day) the sensitivity was 98 % with a cut-off of 0.02 µmol/L PEth, and 93 % for a cut-
off of 0.05 µmol/L PEth. Since this low dose group also consisted of persons who had consumed only 
22 g ethanol per day (roughly two standard drinks per day) as a minimum at baseline, and also no 
alcohol in one of the weeks before the last sample – it is not astonishing that a so called “false 
negative” rate – which on this background actually might be considered “correct negative” one, - was 
found at these cut-offs. 
 
From our own drinking studies, we know, that at low drinking amounts (e.g. a single dose of ethanol, 
35 – 66 g, yielding a blood alcohol concentration (BAC) of 1 ‰ there is only minor accumulation of 
PEth, resulting in detection of low PEth values with a detection window of only 3 up to 12 days 
(Schröck 2014; manuscript in preparation). 
 
For daily “high” – but not “extremely high” consumption, a group with daily doses of 50 – 99 g was 
defined by the authors. The sensitivity of the highest cut-off (0.3 µmol/L) for detection of high 
consumption seems to be very good with 84 %. Furthermore, all samples in this drinking category had 
PEth concentrations of above 0.05 µmol/L (100% sensitivity). However, it is not quite clear, how the 
samples are distributed in this range. Furthermore, this definition is not in line with widely accepted 
ones, such as the NIAAA definition, were drinking more than the below mentioned single-day or 
weekly limits is considered "at-risk" or "heavy" drinking (NIAAA 2015):  For men more than 4 drinks on 
any day or 14 per week and for women more than 3 drin ks on any day or 7 per week. Also, it does not 
match the WHO definition of high risk drinking with 61-100g for men and 41-60 g for women on a 
single day basis or 41+ g for women and 61+ for chronic harm. (WHO, 2000). Of note, this issue is not 
limited to the work of Walther et al, but so many publications and thereby our knowledge on alcohol 
effects would benefit, if standardized and comparable definitions would be used. As indicated by the 
above mentioned NIAAA and WHO levels, gender specific aspects need to be taken into account. This 
is e.g. of importance with regard to the BAC reached for a certain alcohol intake given: According to 
Widmark equation, there is a large difference of BAC among individuals with different bodyweight, 
body water (gender: male/female, fat/thin, athletic). For example, the BAC reached by an 80 kg male 
compared to a 50 kg female when drinking the same amount of alcohol (in gram) can vary by factor 2. 
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Presuming similar elimination rates of ethanol, the area-under-the curve would differ enorumously, 
hence also the formed PEth concentrations. 
 
In addition, the following points hold promise in being addressed in future research:  
 
As PEth seems to be formed as long as alcohol is present in the blood, and higher BAC levels lead to 
a higher formation rate (shown by “in-vitro” experiments (Schröck 2015), the manner of drinking 
(speed, frequency, single drinking amounts) and the BAC reached per drinking event may play a 
crucial role in PEth production. This has not yet been investigated in detail. 
 
Furthermore, it should be considered, that PEth is not only one molecule, but a family of phospholipids 
with different fatty acids in sn-1 and sn-2 position. Nutrition can influence the available lipids to be 
transformed to PEth homologues, and thus can play an important role for the occurrence of different 
fatty acid substituents.  
 
No paper so far looked at degradation of PEth (in-vivo) and mechanism, how PEth is degraded and 
which products are formed. Apart from PLD activity, also PL A1 and A2, PL B and PL C can lead to 
different forms of “lyso”-PEth, which are currently not detected by LC-MS/MS methods. So, there is a 
variety of possibilities to explain inter-individual differences in PEth formation of certain homologues. 
 
In conclusion, there is potentially a plethora of variables apart from daily amount of alcohol consumed, 
which influence PEth concentrations, such as gender (with influence on the area-under-the curve for 
blood alcohol concentration), nutrition and inter-individual differences in enzyme activities (for 
formation or degradation of PEth homologues), among others, which might be promising to be 
considered in future work. 
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